Prof. Alexander Margulis: Hadassah Pediatric Plastic Surgeon and Israel Navy Seal
As his “day job,” Prof. Alex Margulis heads the Hadassah Medical Center’s Pediatric Plastic Surgery and Craniofacial Unit, where children born with birth defects or injured in terrorist attacks are given a new lease on life. At the same time, Prof. Margulis, at age 47, is still active in the Shayetet 13 Reserves, Israel’s Navy Seals Special Forces.
Specializing in sea-to-land incursions, counter-terrorism, sabotage, maritime intelligence gathering, and maritime hostage rescue, Shayetet 13 Seals enter enemy lands to carry out secret operations, stop intruding ships, and protect Israel’s coast.
About his day
job, Prof. Margulis says: "I
love the beauty of this profession which combines medicine and art. It's
tangible and, at the end of the surgery, you can see the results."
Prof. Margulis completed
his residency at Hadassah and then did a two-year fellowship at Chicago
Children's Hospital, where he worked with Dr. Bruce Bauer, a world-famous
plastic surgeon. As for his participation in Shayetet 13, he notes: "I
wanted to be in the most challenging unit possible in the Israel Defense Forces.
I believed I could cope with it and wanted to give my maximum. I've always wanted
to do my most for Israel; I guess it’s a family ethic.”
With 500 beds, 19 stories (five underground) and state-of-the-art technical equipment, the Tower is the most advanced medical facility in the Middle East.
grandfather, Nahum, was the only Margulis to survive the Holocaust.
father, Miron, was a Refusenik who fought, along with Natan Sharansky, for the
right to make Aliyah to Israel. The
family finally received permission to emigrate in 1977 when Alex was 10 years
Married to Irit,
a social worker, Prof. Margulis has three children. "I'm Israeli in my
bones and in my soul,” says Prof.
Margulis. “My dream is still securing freedom for us by overcoming the
internal problems and striving for peace."
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>